PMID- 23122928 OWN - NLM STAT- MEDLINE DCOM- 20130530 LR - 20171116 IS - 1873-3344 (Electronic) IS - 0162-0134 (Linking) VI - 118 DP - 2013 Jan TI - The use of cyclic nitroxide radicals as HNO scavengers. PG - 155-61 LID - S0162-0134(12)00321-2 [pii] LID - 10.1016/j.jinorgbio.2012.10.002 [doi] AB - Reduction of cyclic stable nitroxides (RNO) by HNO to the respective hydroxylamines (RNO-H) has been demonstrated using EPR spectrometry. HNO shows low reactivity toward piperidine, pyrrolidine and nitronyl nitroxides with rate constants below 1.4 x 10(5)M(-1)s(-1) at pH 7.0, despite the high driving force for these reactions. The rate constants can be predicted assuming that the reactions take place via a concerted proton-electron transfer pathway and significantly low self-exchange rate constants for HNO/NO and RNO-H/RNO. NO does not react with piperidine and pyrrolidine nitroxides, but does add to HNO forming the highly oxidizing and moderately reducing hyponitrite radicals. In this work, the radicals are produced by pulse radiolysis and the rate constants of their reactions with 2,2,6,6,-tetramethylpiperidine-1-oxyl (TEMPO), 4-hydroxy-2,2,6,6-tetramethyl piperidine-1-oxyl (TEMPOL) and 3-carbamoyl-PROXYL have been determined at pH 6.8 to be (2.4 +/- 0.2)x 10(6), (9.8 +/- 0.2)x 10(5), (5.9 +/- 0.5)x 10(5)M(-1)s(-1), respectively. This low reactivity implies that NO competes efficiently with these nitroxides for the hyponitrite radical. The ability of TEMPOL and 2-(4-carboxyphenyl)-4,4,5,5,-tetramethyl-imidazoline-1-oxyl-3-oxide (C-PTIO) to oxidize HNO and their different reactivity toward NO are used to quantify HNO formed via acetohydroxamic acid oxidation. The extent of TEMPOL or C-PTIO reduction was similar to the yield of HNO formed upon oxidation by ()OH under anoxia, but not by the metmyoglobin and H(2)O(2) reaction system where both nitroxides catalytically facilitate H(2)O(2) depletion and nitrite accumulation. In this system the conversion of C-PTIO into 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl (C-PTI) is a minor reaction, which does not provide any mechanistic insight. CI - Copyright (c) 2012 Elsevier Inc. All rights reserved. FAU - Samuni, Yuval AU - Samuni Y AD - Oral and Maxillofacial Surgery, The Barzilai Medical Center, Ashkelon, Israel. FAU - Samuni, Uri AU - Samuni U FAU - Goldstein, Sara AU - Goldstein S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121012 PL - United States TA - J Inorg Biochem JT - Journal of inorganic biochemistry JID - 7905788 RN - 0 (Benzoates) RN - 0 (Cyclic N-Oxides) RN - 0 (Free Radical Scavengers) RN - 0 (Free Radicals) RN - 0 (Hydroxamic Acids) RN - 0 (Hydroxylamines) RN - 0 (Imidazoles) RN - 0 (Nitrites) RN - 0 (Nitrogen Oxides) RN - 0 (Oxidants) RN - 12772-23-5 (Metmyoglobin) RN - 14448-38-5 (hyponitrite) RN - 145757-47-7 (1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole) RN - 2FP81O2L9Z (Hydroxylamine) RN - 4RZ82L2GY5 (acetohydroxamic acid) RN - BBX060AN9V (Hydrogen Peroxide) RN - GFQ4MMS07W (nitroxyl) RN - V55XB6IT82 (TEMPOL-H) RN - VQN7359ICQ (TEMPO) SB - IM MH - Benzoates/chemistry MH - Cyclic N-Oxides/*chemistry MH - Electron Spin Resonance Spectroscopy MH - Free Radical Scavengers/*chemistry MH - Free Radicals/*chemistry MH - Hydrogen Peroxide/chemistry MH - Hydroxamic Acids/chemistry MH - Hydroxylamine/*chemistry MH - Hydroxylamines/chemistry MH - Imidazoles/chemistry MH - Kinetics MH - Metmyoglobin/chemistry MH - Models, Chemical MH - Nitrites/chemistry MH - Nitrogen Oxides/*chemistry MH - Oxidants/chemistry MH - Oxidation-Reduction MH - Pulse Radiolysis EDAT- 2012/11/06 06:00 MHDA- 2013/06/01 06:00 CRDT- 2012/11/06 06:00 PHST- 2012/05/21 00:00 [received] PHST- 2012/09/11 00:00 [revised] PHST- 2012/10/04 00:00 [accepted] PHST- 2012/11/06 06:00 [entrez] PHST- 2012/11/06 06:00 [pubmed] PHST- 2013/06/01 06:00 [medline] AID - S0162-0134(12)00321-2 [pii] AID - 10.1016/j.jinorgbio.2012.10.002 [doi] PST - ppublish SO - J Inorg Biochem. 2013 Jan;118:155-61. doi: 10.1016/j.jinorgbio.2012.10.002. Epub 2012 Oct 12.